Insmed Incorporated

NasdaqGS:INSM Lagerbericht

Marktkapitalisierung: US$12.5b

Insmed Management

Management Kriterienprüfungen 3/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Will Lewis

Geschäftsführender

US$10.4m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts7.5%
Amtszeit als Geschäftsführer12yrs
Eigentum des Geschäftsführers0.3%
Durchschnittliche Amtszeit des Managements4.8yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder10.3yrs

Jüngste Management Updates

Recent updates

Insmed Incorporated's (NASDAQ:INSM) Share Price Not Quite Adding Up

Sep 12
Insmed Incorporated's (NASDAQ:INSM) Share Price Not Quite Adding Up

Insmed: Brensocatib Propels Stock As Regulatory Milestones Approach

Aug 28

Is Insmed (NASDAQ:INSM) A Risky Investment?

Aug 10
Is Insmed (NASDAQ:INSM) A Risky Investment?

Insmed Incorporated's (NASDAQ:INSM) 92% Share Price Surge Not Quite Adding Up

May 29
Insmed Incorporated's (NASDAQ:INSM) 92% Share Price Surge Not Quite Adding Up

Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade)

May 28

Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Feb 25
Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Dec 18
Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Jul 28
Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Jul 01
Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

Apr 18
Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Feb 23
A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Insmed inks financing agreements to raise $500M

Oct 19

Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

Oct 17
Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Sep 20
An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Insmed rises 16% on better-than-expected Q2 result

Aug 04

Is Insmed (NASDAQ:INSM) A Risky Investment?

Jun 24
Is Insmed (NASDAQ:INSM) A Risky Investment?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Will Lewis im Vergleich zu den Einnahmen von Insmed verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

-US$803m

Mar 31 2024n/an/a

-US$747m

Dec 31 2023US$10mUS$780k

-US$750m

Sep 30 2023n/an/a

-US$724m

Jun 30 2023n/an/a

-US$696m

Mar 31 2023n/an/a

-US$547m

Dec 31 2022US$8mUS$735k

-US$482m

Sep 30 2022n/an/a

-US$434m

Jun 30 2022n/an/a

-US$416m

Mar 31 2022n/an/a

-US$438m

Dec 31 2021US$7mUS$710k

-US$435m

Sep 30 2021n/an/a

-US$424m

Jun 30 2021n/an/a

-US$375m

Mar 31 2021n/an/a

-US$319m

Dec 31 2020US$6mUS$660k

-US$294m

Sep 30 2020n/an/a

-US$245m

Jun 30 2020n/an/a

-US$242m

Mar 31 2020n/an/a

-US$247m

Dec 31 2019US$7mUS$641k

-US$254m

Sep 30 2019n/an/a

-US$293m

Jun 30 2019n/an/a

-US$320m

Mar 31 2019n/an/a

-US$330m

Dec 31 2018US$6mUS$610k

-US$324m

Sep 30 2018n/an/a

-US$298m

Jun 30 2018n/an/a

-US$256m

Mar 31 2018n/an/a

-US$224m

Dec 31 2017US$4mUS$567k

-US$193m

Vergütung im Vergleich zum Markt: WillDie Gesamtvergütung ($USD10.41M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD13.21M).

Entschädigung vs. Einkommen: WillDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.

Geschäftsführer

Will Lewis (55 yo)

12yrs

Amtszeit

US$10,411,260

Vergütung

Mr. William H. Lewis, also known as Will, J.D. M.B.A. serves as an Independent Chairman of Board of Directors of NewAmsterdam Pharma Company N.V. from January 2024. He has been Chief Executive Officer and...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
William Lewis
President12yrsUS$10.41m0.26%
$ 32.8m
Sara Bonstein
Chief Financial Officer4.7yrsUS$4.56m0.011%
$ 1.3m
Roger Adsett
Chief Operating Officer4.8yrsUS$4.01m0.037%
$ 4.6m
John Wise
Chief Commercial Officer4.8yrsUS$3.89m0.030%
$ 3.8m
Martina Flammer
Chief Medical Officer4.8yrsUS$4.22m0.0074%
$ 925.4k
Brian Kaspar
Chief Scientific Officerno datakeine Datenkeine Daten
Eleanor Barisser
Associate Director of Investor Relationsno datakeine Datenkeine Daten
Michael Smith
Chief Legal Officer & Corporate Secretary3.2yrskeine Daten0.039%
$ 4.9m
Mandy Fahey
Executive Director of Corporate Communicationsno datakeine Datenkeine Daten
S. Schaeffer
Chief People Strategy Officer11.7yrsUS$2.66m0.020%
$ 2.5m
Eugene Sullivan
Chief Product Strategy Officer7.3yrsUS$1.69mkeine Daten
Neil Hughes
GM & Head of Europe5.3yrskeine Datenkeine Daten

4.8yrs

Durchschnittliche Betriebszugehörigkeit

55yo

Durchschnittliches Alter

Erfahrenes Management: INSMDas Führungsteam des Unternehmens gilt als erfahren (4.8 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
William Lewis
President12yrsUS$10.41m0.26%
$ 32.8m
David W. McGirr
Independent Director10.9yrsUS$320.00k0.050%
$ 6.2m
Melvin Sharoky
Independent Director23.3yrsUS$312.50k0.19%
$ 23.7m
Alfred Altomari
Independent Director12.1yrsUS$320.00k0.033%
$ 4.1m
David Brennan
Lead Independent Director10.3yrsUS$345.00k0.063%
$ 7.9m
Clarissa Desjardins
Independent Director4.8yrsUS$315.00k0.028%
$ 3.6m
Elizabeth Anderson
Independent Director5.8yrsUS$310.00k0.032%
$ 4.0m
Leo Lee
Independent Director6.3yrsUS$317.50k0.065%
$ 8.1m
Carol Schafer
Independent Director4.4yrsUS$315.00k0.026%
$ 3.3m

10.3yrs

Durchschnittliche Betriebszugehörigkeit

65yo

Durchschnittliches Alter

Erfahrener Vorstand: INSMDie Vorstandsmitglieder sind sehr erfahren ( 10.3 ).